Copyright
©The Author(s) 2025.
World J Clin Pediatr. Sep 9, 2025; 14(3): 104689
Published online Sep 9, 2025. doi: 10.5409/wjcp.v14.i3.104689
Published online Sep 9, 2025. doi: 10.5409/wjcp.v14.i3.104689
Table 1 Clinical characteristics of 20 Russian mucopolysaccharidosis II patients who died between 2016-2022 years
ID | Height at birth, cm | 1st-year psychomotor delay | Delayed mental and speech | Intellectual disability: | Hydrocephalus | Epilepsy | Swallow disorders | Independent walking 5-12 / > 12 year | Hurler pheno-type | Cardio-myopathy | Myxomatous valve degeneration | Respiratory disorders | Tracheostomy | Carpal tunnel syndrome |
46 | 49 | No | Yes | No/no | Yes | No | No | Yes/yes | Yes | Yes | Yes | 0 | 0 | 0 |
58 | N/A | N/A | N/A | N/A/N/A | N/A | N/A | No | N/A/N/A | Yes | N/A | N/A | N/A | N/A | N/A |
65 | 52 | No | Yes | Mod/profound | Yes | Yes | Yes | Yes/no | Yes | Yes | Yes | Yes | 0 | Yes |
71 | 57 | Yes | No | No/no | N/A | N/A | N/A | Yes/yes | Yes | N/A | N/A | Yes | N/A | N/A |
72 | N/A | Yes | Yes | No/no | N/A | Yes | Yes | Yes/no | Yes | No | Yes | Yes | 0 | 0 |
92 | 52 | No | Yes | No/N/A | Yes | Yes | Yes | No/N/A | Yes | No | Yes | Yes | 0 | Yes |
93 | 51 | No | Yes | Profound/profound | No | Yes | Yes | No/no | Yes | No | Yes | Yes | Yes | Yes |
96 | 52 | No | Yes | Severe/severe | No | Yes | Yes | Yes/no | Yes | Yes | Yes | 0 | 0 | Yes |
104 | N/A | Yes | Yes | No/no | Yes | No | Yes | No/no | Yes | Yes | Yes | 1 | 0 | N/A |
106 | 50 | Yes | Yes | No/not significant | No | N/A | N/A | N/A/N/A | Yes | No | Yes | N/A | N/A | N/A |
109 | 57 | Yes | Yes | Moderate/severe | Yes | Yes | Yes | Yes/no | Yes | No | Yes | Yes | 0 | Yes |
110 | N/A | No | No | No/no | Yes | No | No | Yes/yes | Yes | No | Yes | Yes | 0 | Yes |
111 | 57 | Yes | Yes | Not significant/profound | Yes | Yes | Yes | Yes/no | Yes | Yes | Yes | Yes | 0 | Yes |
113 | 51 | N/A | N/A | N/A/N/A | N/A | N/A | N/A | N/A/N/A | Yes | N/A | N/A | N/A | N/A | N/A |
116 | 55 | Yes | Yes | Severe/N/A | Yes | N | Yes | N/A/N/A | Yes | Yes | Yes | 1 | 0 | 1 |
120 | N/A | No | No | No/no | N/A | N/A | N/A | Yes/no | N/A | N/A | N/A | N/A | N/A | N/A |
124 | 56 | Yes | Yes | No/severe | Yes | No | Yes | Yes/yes | Yes | Yes | Yes | Yes | 0 | 0 |
144 | N/A | No | Yes | No/N/A | Yes | No | No | Yes/N/A | Yes | N/A | N/A | Yes | 0 | Yes |
147 | 54 | No | No | No/no | No | No | No | Yes/yes | Yes | Yes | Yes | Yes | Yes | Yes |
149 | 51 | Yes | Yes | Moderate/profound | Yes | Yes | Yes | Yes/no | Yes | Yes | Yes | Yes | Yes | Yes |
- Citation: Buchinskaya N, Vechkasova A, Vashakmadze N, Namazova-Baranova L, Ivanov D, Zakharova E, Kutsev S, Kostik M. Analysis of fatal outcomes of patients with mucopolysaccharidosis type II according to the Russian mucopolysaccharidosis registry. World J Clin Pediatr 2025; 14(3): 104689
- URL: https://www.wjgnet.com/2219-2808/full/v14/i3/104689.htm
- DOI: https://dx.doi.org/10.5409/wjcp.v14.i3.104689